Connect with us
Incannex Healthcare Inc. (Nasdaq: IXHL) saw a smaller annual loss as the freshly-financed firm ramps up research efforts for its oral cannabinoids and psychedelic treatments. The...
HYTN Innovations Inc. (CSE: HYTN) acquired Prism Scientific Labs Inc. for approximately $242,000 in an all-stock deal. The Vancouver-based firm bought all outstanding shares of Prism...
A global survey revealed that most mental health care workers would consider integrating psychedelic treatments into their practices if such modalities were legalized in their countries....
The sale aligns with Psyence Group’s latest lean towards an asset-light business model. Psyence Group (CSE: PSYG) said it will sell its 11.13% stake in PsyLabs...
Following a reverse share split, Cybin Inc. (NYSE American: CYBN) updated investors on the company’s pipeline. Share consolidation On Thursday, Cybin completed its share consolidation to...
A European citizens’ initiative aimed at promoting psychedelic-assisted treatments for mental health disorders has been registered by the European Commission. The initiative, dubbed “PsychedeliCare,” was registered...
Psyence Biomedical Ltd (Nasdaq: PBM) is poised to hit several psilocybin-related “milestones” in coming months, including the acquisition of drug developer Clairvoyant, the launch of research...
A recent U.S. Food and Drug Administration meeting on post-traumatic stress disorder treatments has reignited, within more official channels, the debate over the agency’s decision last...
The U.S. Department of Justice announced that the chief executive officer of psilocybin company Minerco Inc. (OTC: MINE), Julius Jenge was arrested on Aug. 22 at...
The one-for-ten reverse split for the AdvisorShares Psychedelics ETF starts with today’s trading. The split will not change the total value of a shareholder’s investment. That...
